Document Detail

Antibiotic prophylaxis, body piercing and infective endocarditis.
MedLine Citation:
PMID:  14688049     Owner:  NLM     Status:  MEDLINE    
Infective endocarditis (IE) is associated with a high degree of morbidity and mortality and generally presents in patients with altered and abnormal heart architecture combined with exposure to bacteria through trauma and other potentially high-risk activities, including body piercing. Modern social behaviour has resulted in increased popularity of the practice of body piercing, particularly amongst the adolescent population and there has been a marked rise of cases of IE directly attributable to this practice. In this article we wish to examine the aetiology of such cases reported in the literature, with particular emphasis on causal organism, as well as to discuss the role of antibiotic prophylaxis and awareness in such at-risk patients within the primary care community.
Beverley C Millar; John E Moore
Related Documents :
22207249 - Chilblain lupus induced by tnf-α antagonists: a case report and literature review.
18029099 - Endocarditis in burn patients: clinical and diagnostic considerations.
22036829 - Rituximab - shadow, illusion or light?
1411579 - Septic subdeltoid bursitis.
11147029 - Aspergillus endocarditis in a lung transplant recipient. a case report and review of th...
18304019 - Infective endocarditis with abiotrophia defectiva: the first australian experience.
7427049 - Subclavian and axillary vein compression of musculoskeletal origin.
9032859 - Two cases of gamma knife radiosurgery for low-grade optic chiasm glioma.
19815479 - Surgery plus targeted therapy for renal cell carcinoma with isolated spermatic cord met...
Publication Detail:
Type:  Journal Article; Review     Date:  2003-12-19
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  53     ISSN:  0305-7453     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-02-02     Completed Date:  2004-04-20     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  England    
Other Details:
Languages:  eng     Pagination:  123-6     Citation Subset:  IM    
Northern Ireland Public Health Laboratory, Department of Bacteriology, Belfast City Hospital, Lisburn Road, Belfast BT9 7AD, Northern Ireland, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use*
Endocarditis, Bacterial / etiology*,  mortality,  prevention & control*
Heart Diseases / complications
Risk Factors
Reg. No./Substance:
0/Anti-Bacterial Agents
Comment In:
J Antimicrob Chemother. 2004 Jul;54(1):278   [PMID:  15128730 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfl...
Next Document:  Trends in the treatment of orthopaedic prosthetic infections.